Drugs / VT7208
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07085507 | Aug 2025 → Oct 2026 expected | multiple sclerosis | Vidya Therapeutics Inc | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VT7208 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07085507 ↗ |
| Modality | Small molecule | “a small synthetic molecule capsule, oral” NCT07085507 ↗ |
| Route | Oral | “a small synthetic molecule capsule, oral” NCT07085507 ↗ |